Clinical Trial Update: BMT and High Dose Post-Transplant Cyclophosphamide for Chimerism Induction and Renal Allograft Tolerance [Phase 2]

View source ↗

Summary

Phase 2 trial investigating bone marrow transplant with high-dose post-transplant cyclophosphamide for chimerism induction and renal allograft tolerance in kidn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Kidney Transplantation | Phase 2 | Status: TERMINATED | Results posted: 2018-09-19